Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...
Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside ...
Insilico Medicine announced LabClaw, an intelligent laboratory operating system designed to enable autonomous coordination ...
This eBook is designed to deliver both strategic insight and practical guidance. It opens with a White Paper informed by ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
AI is transforming drug discovery, but accurately predicting patient responses remains challenging. Considering the ongoing need to connect drugs with the right patients and rising drug costs, ...
A new analysis of the Alzheimer's drug development pipeline, led by Goodes Prize winner and longtime Alzheimer's Drug Discovery Foundation (ADDF) collaborator Dr. Jeff Cummings; Joy Chambers-Grundy ...
When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...
Drug development involves significant risk and expense. With average development costs topping $1 billion per approved medicine and stubbornly high failure rates, pharmaceutical leaders are ...
Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results